baber/WOPTO huggingface dataset:
Patent DK-0526524-T3 (DK)
Inventor: TOVEY GEOFFREY DAVID
IPC: A61K9/20
Filed: 1991-04-24
Granted: 1996-01-29
Abstract: Pharmaceutical compositions in the form of a wafer for the delivery of medicaments to the sub-lingual mucosa are described.
Patent DK-0504349-T3 (DK)
Inventor: YEN KWANG-MU
IPC: C12N15/78
Filed: 1991-08-21
Granted: 2001-09-24
Abstract: Disclosed and claimed are toluene monooxygenase (TMO) gene sequences from Pseudomonas mendocina KR-1, TMO proteins encoded by these sequences, recombinant plasmids containing such sequences, and microorganism host cells containing such plasmids. A five-gene and six-gene TMO gene cluster encode proteins that are useful in a variety of bioconversions. In particular, the TMO gene cluster is useful for the preparation of p-hydroxyphenylacetic acid and indigo. In addition, the TMO gene cluster is useful for the degradative bioconversion of toxic compounds, such as trichloroethylene.
Patent DK-0560782-T3 (DK)
Inventor: OLIFF JAMES R
IPC: B65D71/12
Filed: 1991-09-19
Granted: 1996-01-29
Abstract: A carton formed from a unitary blank for packaging a plurality of cans includes a top wall, side walls, foldably joined along their top edges respectively to opposite side edges of the top wall, a pair of lap panels foldably joined respectively to the bottom edges of the side walls and secured together in overlapping relation to form a composite bottom wall of the carton, an anchoring panel foldably joined to each end edge of each side wall and folded into flat face contacting relation with the inner surface of the associated side wall, masking structure for overlying the pricing indicia applied to individual cans, includes a masking panel foldably joined to each end edge of each lap panel and arranged with the inner edges thereof disposed in overlapping relation together with web structure foldably joined along one edge thereof to the adjacent edge of the associated anchoring panel and foldably joined along another edge thereof to the adjacent end of the associated masking panel.
Patent DK-0572497-T3 (DK)
Inventor: LARSSON SUNE
IPC: A01G23/091
Filed: 1992-02-05
Granted: 1996-02-12
Abstract: PCT No. PCT/SE92/00067 Sec. 371 Date Nov. 29, 1993 Sec. 102(e) Date Nov. 29, 1993 PCT Filed Feb. 5, 1992 PCT Pub. No. WO92/14352 PCT Pub. Date Sep. 3, 1992.The present invention relates to an arrangement in a tree-processing assembly of the type comprising a frame base (2) which is connectible to the tip of a crane via a rotator (3) and with which a pivotable carrier (5) is hingedly connected, said carrier comprising at least one set of grapples (6, 6', 6'') for gripping and holding a log, and a cutting tool, such as a chain-saw guide bar (12), attached to the lower part (11) of the carrier. On the lower part (11) of the carrier (5) there is mounted a rotary saw blade (15) which is pivotably movable between an inactive position in which it is swung in towards the carrier, and an active position in which it is swung out from the carrier and in which it can cut, by means of an outer half, a shrub layer and/or small trees.
Patent DK-0574586-T3 (DK)
Inventor: YOSHIDA NOBUKO
IPC: A23L27/24
Filed: 1992-11-12
Granted: 1997-02-10
Abstract: A process for producing food and drink having favorable taste by giving an aroma thereto, which comprises adding thereto during the production thereof an enzyme originating in animals and having the activity of synthesizing esters (in terms of ethyl butyrate) of at least 0.1 unit/mg of protein in the enzymatic reaction for which 0.5 % (w/w) of ethanol and 2.6 % (w/w) of butyric acid are used as the basic agents, or a substance containing said enzyme.
Patent DK-0581209-T3 (DK)
Inventor: BEHREND VOLKMAR
IPC: B63B19/18
Filed: 1993-07-23
Granted: 1995-12-27
Abstract: A ship's crane is proposed, in particular for transporting, lifting and lowering pallets which are preferably arranged in a cage connected to the lifting gear. Here, the crane structure is movable on tracks or the like transversely to the longitudinal direction of the ship, and the area of the crane structure accommodating the pallets, in particular the cage, including the respective hatch and the displacement path, is surrounded by essentially fully enclosed weather protection. <IMAGE>
Patent DK-0595458-T3 (DK)
Inventor: HIDEYUKI SHIOZAWA
IPC: C07D495/04
Filed: 1993-09-17
Granted: 1999-06-23
Abstract: Two thiomarinol derivatives, which have antibacterial and anti-mycoplasmal properties, are obtainable from microorganisms of the genus Alteromonas and are named "thiomarinol B" and "thiomarinol C". Thiomarinol B can also be prepared by the oxidation of thiomarinol.
Patent DK-0618912-T3 (DK)
Inventor: APPLER HEINZ
IPC: A01P3/00
Filed: 1992-12-15
Granted: 1996-12-09
Abstract: PCT No. PCT/EP92/02907 Sec. 371 Date Jun. 13, 1994 Sec. 102(e) Date Jun. 13, 1994 PCT Filed Dec. 15, 1992 PCT Pub. No. WO93/13085 PCT Pub. Date Jul. 8, 1993.Substantially dust-free granules of tetrahydro-3,5-dimethyl-1,3,5-thiadiazine-2-thione (I) are prepared by reacting methylamine (II) with carbon disulfide (III) and formaldehyde (IV) or by reacting the methylammonium salt of N-methyldithiocarbamic acid (V) with formaldehyde (IV) by a process in which the reaction is carried out in the presence of at least one diaminoalkylene of the formula VI R1-NH-A-NH-R2 VI where R1 and R2 independently of one another are each hydrogen or alkyl and A is an unsubstituted or substituted 1,2-ethylene, 1,3-propylene or 1,4-butylene bridge.
Patent DK-0623670-T3 (DK)
Inventor: CLAPPERTON RICHARD MALCOLM
IPC: C11D1/86
Filed: 1994-05-09
Granted: 2001-09-24
Abstract: The use of a stabiliser comprising a hydrophilic polymeric chain of more than four hydrophilic monomer groups and/or having a mass greater than 300 amu, linked at one end to a hydrocarbon-soluble hydrophobic group to reduce or prevent the flocculation of systems comprising a flocculable surfactant and a liquid medium which is capable of flocculating said surfactant and in which said stabiliser is capable of existing as a micellar solution at a concentration of at least 1% by weight.
Patent DK-0648779-T3 (DK)
Inventor: SCHUBERT GERD DR
IPC: C07J41/00
Filed: 1994-07-07
Granted: 1997-09-15
Abstract: 11-Benzaldoxime-oestradiene derivatives of the general formula I <IMAGE> and their pharmaceutically acceptable salts, a process for their preparation and pharmaceutical compositions containing them are described. The described compounds display potent antigestagenic effects with lower glucocorticoid activity.
Patent DK-0712827-T3 (DK)
Inventor: HIRAZAWA KIYOSHI
IPC: C07C29/10
Filed: 1994-08-08
Granted: 1999-09-20
Abstract: A process for producing D-chiro-inositol which comprises either mixing an aqueous solution of kasugamycin or a salt thereof with a strongly acidic ion-exchange resin (of H<+> type) in a reactor or bringing the aqueous solution into contact with the resin in a column packed therewith, heating the aqueous solution and the resin under normal or applied pressure to effect hydrolysis of kasugamycin to thereby prepare an acidic reaction solution containing D-chiro-inositol, separating the acidic reaction solution from the resin, and recovering D-chiro-inositol from the solution. In this stage, it is possible to obtain efficiently high-purity D-chiro-inositol by passing the acidic reaction solution first through a column packed with a strongly acidic ion-exchange resin (of H<+> type) and then through another column packed with a strongly basic ion-exchange resin (of OH<-> type) to prepare a neutral eluate containing D-chiro-inositol, and concentrating the eluate to effect deposition of D-chiro-inositol crystals.
Patent DK-0650571-T3 (DK)
Inventor: ANDERSON DAVID K
IPC: F23C5/32
Filed: 1994-03-17
Granted: 1998-12-28
Abstract: An integrated low NOx tangential firing system (12) that is particularly suited for use with pulverized solid fuel-fired furnaces (10), and a method of operating a pulverized solid fuel-fired furnace (10) equipped with an integrated low NOx tangential firing system (12). The integrated low NOx tangential firing system (12) when so employed with a pulverized solid fuel-fired furnace (10) is capable of limiting NOx emissions therefrom to less than 0.15 lb./10 6 BTU, while yet maintaining carbon-in-flyash to less than 5% and CO emissions to less than 50 ppm. The integrated low NOx tangential firing system (12) includes pulverized solid fuel supply means (62), flame attachment pulverized solid fuel nozzle tips (60), concentric firing nozzles, close-coupled overfire air (98,100), and multi-staged separate overfire air (104,106).
Patent DK-0719084-T3 (DK)
Inventor: WILKINS LEON M
IPC: A01N1/02
Filed: 1994-09-14
Granted: 2002-04-08
Abstract: This invention is directed to cryopreservation of cultured tissue equivalents made by in vitro technology. The invention involves immersing a cultured tissue equivalent in a cooled cryoprotectant solution, agitating the cryoprotectant solution and the immersed cultured tissue to achieve effective penetration of the cryoprotectant solution into the cultured tissue equivalent, and then freezing the cultured tissue at a high freezing rate. The cryopreserved cultured tissue equivalent may be stored for indefinite periods of time prior to use. The cultured tissue equivalent is an in vitro model of the equivalent human tissue, which, when retrieved from storage can be used for transplantation or implantation in vivo or for screening compounds in vitro.
Patent DK-0699766-T3 (DK)
Inventor: GAYLE MARGIT ANN
IPC: A61K47/48
Filed: 1991-01-21
Granted: 2003-03-17
Abstract: The present invention relates to a system for the generation of antibody fusion proteins which has utility in the production of recombinant molecules that possess novel, clinically relevant biological activity. The antibody fusion proteins of the invention may be used therapeutically to deliver biologically active ligands to a desired tissue. In particular embodiments of the invention, the antibody fusion protein comprises an immunoglobulin variable region and a biologically active ligand which is a non-lymphokine cellular factor. In a specific embodiment of the invention, a fused antibody is produced which comprises a variable region of the anti-tumor antigen monoclonal antibody L6 and active platelet factor 4, a molecule associated with antagonism of angiogenesis, inhibition of suppressor T lymphocyte development, chemotaxis and heparin binding.
Patent DK-0718199-T3 (DK)
Inventor: RIZZIERI GIORGIO
IPC: B65B9/04
Filed: 1995-12-14
Granted: 2000-07-24
Abstract: Process and plant for packaging in the fluid state substances which are sticky or soft at room or handling temperature, wherein the substance (A) is cast in a mould (1) provided with holes and lined, by means of vacuum thermoforming, with a thin film of plastic material (4) which is non-sticky at the room temperature and compatible, in the fluid state, with the sticky or soft substance (stage I). The free-surface of this substance thus formed is cooled (stage II) and finally covered with a non-sticky material (25) which is then heat-sealed with the film (stage III). The sealed materials are finally cut in the region of the sealed joint (stage IV). <IMAGE>
Patent DK-0743060-T3 (DK)
Inventor: TIMMER CHRISTIENA JANNIE
IPC: A61K38/44
Filed: 1995-04-28
Granted: 2003-03-17
Abstract: The present invention is related to a mouth-care product comprising an effective amount of colostrum and/or a colostrum extract, preferably based on bovine colostrum.
Patent DK-0709862-T3 (DK)
Inventor: JOULIE RENE
IPC: H01B19/00
Filed: 1995-10-25
Granted: 1999-02-01
Abstract: The method involves fixing the end connector rings (20) in supports (12,13). The supports and the rings are fabricated so that the diameter of the rings (20) is slightly smaller than the diameter of the supports (12,13). The rings are heated to expand the ring diameter sufficiently so that they become slightly larger than the supports diameter, so as to be able to insert the rings on the supports. The bushing insulator (1) is then fixed on the supports by adhesive. The surface of the rings are machined with striations to create adhesive seals.
Patent DK-0745122-T3 (DK)
Inventor: AMIRANOFF BRIGITTE
IPC: C12P21/02
Filed: 1995-02-14
Granted: 2009-03-30
Abstract: Polypeptides having galinin receptor activity, genetic material for expressing same, any recombinant cell expressing said polypeptides, and the use thereof, are disclosed.
Patent DK-0748553-T3 (DK)
Inventor: BADII-AZANDAHI SAHBA
IPC: H04M1/677
Filed: 1995-03-02
Granted: 1999-02-15
Abstract: A telephone dialling monitoring and selecting apparatus (2) comprises a first connector (3) for connecting the unit, in use, to a telephone line and a second connector for connecting the unit, in use, to a telephone unit (1). The apparatus (2) also comprises telephone dialling monitoring means (4) connected to both the first and second connectors, for monitoring dialling signals from the telephone unit, and outputting signals to the telephone line in accordance with the monitored dialling signal and data stored in the monitoring means. There is also provided, within the apparatus (2), means (6, 7, C1 to C3, R1 to R5) for separating AC and DC signals provided via the telephone line and directing the AC signal and a portion of the DC signal to the telephone unit and a further portion of the DC signal to the monitoring means in order to power the apparatus.
Patent DK-0749284-T3 (DK)
Inventor: ZELNIKER DAVID
IPC: A47L15/44
Filed: 1995-03-02
Granted: 2000-01-31
Abstract: A dishwashing machine is provided for washing dishes with a very rapid washing cycle in which water and detergent are sprayed through different spraying nozzles in different operational stages within the dishwashing cycle.
Patent DK-0805803-T3 (DK)
Inventor: BRIEDEN WALTER
IPC: C07D241/06
Filed: 1996-01-19
Granted: 2003-02-17
Abstract: 1,4,5,6-tetrahydropyrazine-2-carboxamides of formula: wherein R1 is hydrogen, alkyl, cycloalkyl or arylalkyl; R2 is alkyl, aryl, or arylalkyl and R3, R4 and R5 are hydrogen, acyl, aryl or arylalkyl or R2 forms an alicyclic system with R3 or R4 and the adjacent carbon atom(s), R6 being hydrogen or a group of formula R7-C(=O)- wherein R7 is hydrogen or alkyl. These compounds can be used in the production of piperazine carboxamides.
Patent DK-0805196-T3 (DK)
Inventor: VAN DEN KOMMER MARCEL
IPC: C11B7/00
Filed: 1994-07-15
Granted: 2000-04-25
Abstract: Process for triglyceride oil fractionation using a crystallisation modifying substance which is a copolymer having subunits A and B of which subunit A is derived from maleic acid or itaconic acid and subunit B is derived from vinyl alcohol, alkyl substituted vinyl alcohol, acrylic acid or styrene, A and B being present in a ratio of 10:1 to 1:10, where 5-100% of the the maleic acid or itaconic acid subunits are connected to unbranched (C8-C24)-alkyl chains and where 0-100% of the vinyl alcohol or alkyl substituted vinyl alcohol or acrylic acid subunits are connected to unbranched (C1-C8)-alkyl chains.
Patent DK-0835684-T3 (DK)
Inventor: WILKINS ANTHONY JOHN JOSEPH
IPC: F01N3/02
Filed: 1997-09-30
Granted: 2004-03-22
Abstract: An emission control system for internal combustion engines which emit carbonaceous soot particles, comprises a first catalyst effective to oxidise NO to NO2 and a second catalyst effective at least to oxidise hydrocarbons, carbon monoxide and volatile organic fractions, each catalyst being supported on a honeycomb flow-through monolith comprising a plurality of cells, each defined by a cell wall, whereby soot particles trapped on or within said second catalyst monolith are combusted in the NO2-containing gas from said first catalyst, and wherein the first catalyst is supported on a flexible metal monolith whereby flexing and/or vibration of the honeycomb cell walls serves to minimise the collection of soot particles thereon. <IMAGE>
Patent DK-0914148-T3 (DK)
Inventor: ATTIE KENNETH M
IPC: C07K14/72
Filed: 1997-04-18
Granted: 2003-11-24
Abstract: Methods of increasing the growth rate of a human patient having partial growth hormone insensitivity syndrome, but not Laron syndrome, are described. One such method comprises administering an effect dose of growth hormone, preferably growth hormone with a native human sequence, with or without an N-terminal methionine, to the patient. The patient is characterized as having a height of less than about -2 standard deviations below normal for age and sex, a serum level of high-affinity growth hormone binding protein that is at least 2 standard deviations below normal levels, a serum level of IGF-I that is below normal mean levels, and a serum level of growth hormone that is at least normal. In another such method, the same patient population is treated with an effective amount of IGF-I, given alone or in combination with an amount of growth hormone that is effective in combination with the IGF-I. <IMAGE>
Patent DK-0915725-T3 (DK)
Inventor: MEIBOCK ANTONIN A
IPC: A43B5/16
Filed: 1997-06-18
Granted: 2002-07-01
Abstract: A skate for receiving a foot of a skater includes a frame holding in-line wheels. A rigid base is securely attached to the frame. An external heel counter extends upwardly from the base around the heel portion of the skate. An upper having an outer shell of substantially soft pliable material extends upwardly from the base. A substantially rigid internal heel counter is disposed beneath the outer shell. The internal heel counter extends around the heel area of the skate above the top of said external heel counter. A substantially rigid ankle support cuff is pivotally coupled to the internal heel counter and disposed beneath the outer shell.
Patent DK-0983002-T3 (DK)
Inventor: HERRICK JAMES PETER
IPC: A23L33/20
Filed: 1998-04-20
Granted: 2005-11-21
Abstract: A process and an apparatus for the production of a new reduced fat culinary sauce which comprises mixing the ingredients of a reduced fat culinary sauce whereby part of the fat present in a regular culinary sauce is substituted by water, controlling the water activity to a value less than 0.95, mixing or precooking below 160 DEG  F. and then processing for a minimum of 0.87 minutes by continuous steam injection and holding at a temperature of at least 160 DEG  F.
Patent DK-0976896-T3 (DK)
Inventor: HANKEL WILLI
IPC: E05B47/06
Filed: 1999-06-16
Granted: 2001-05-28
Abstract: The inner rotary knob (120) is connected rotation proof with a sleeve (12), on which the locking element (30) is arranged rotation proof. The outer rotary knob (50) is connected rotation proof with a shaft (52) extending through the sleeve (12) of the inner rotary knob (10), and is connected rotation proof with a coupling unit (40) arranged in the inner rotary knob.
Patent DK-1026432-T3 (DK)
Inventor: RUEECK GERHARD
IPC: F16L23/22
Filed: 1999-11-10
Granted: 2006-10-30
Abstract: One(13) of the connecting elements on the end face facing a seal(12) has a second housing for the seal and conforming to the shape of the seal. The two housings(24,31) for the seal, when the connector is assembled, accommodate the seal in the region of the inner wall of the pipe with no cavity or undercut. The seal by forming a bead(33) is installed between encircling edges of the housings. A profile on the circumferential face(19) of the first connecting element is a component part of a bayonet connection(22) which includes a retaining pin installed on the inner wall of the connector.
Patent DK-1089319-T3 (DK)
Inventor: COLPO PASCAL
IPC: B01J19/08
Filed: 1999-09-29
Granted: 2009-04-06
Abstract: The apparatus generates a time-varying magnetic field through a field admission window (22) of a plasma processing chamber (20) to create or sustain a plasma within the chamber by inductive coupling. It comprises:   a magnetic core (38) presenting a unipolar pole face structure (38a)   an inductor means (40) associated with the magnetic core, for generating a time-varying magnetic field throughout the unipolar pole face structure, means (42,44,48,51) for injecting gas into said chamber and through said magnetic core.   <IMAGE>
Patent DK-1135479-T3 (DK)
Inventor: HILLEBRAND TIMO
IPC: C12N15/10
Filed: 1999-07-23
Granted: 2003-04-07
Abstract: The subject of the invention are formulations not containing chaotropic components for isolating nucleic acids with binding to a solid phase, in particular of DNA, from optional complex starting materials and quantities containing a lysis/binding buffer system which comprises at least one antichaotropic salt component, a solid phase and wash and elution buffers known as such. The lysis/binding buffer system may be an aqueous solution or a solid formulation in reaction vessels ready for use. All carriers used for isolation by means of chaotropic reagents, preferably glass fiber mats, glass membranes, silica carriers, ceramics, zeolites or materials showing negatively functionalised surfaces or chemically modified surfaces which may be converted to a negative charge potential may serve as a solid phase.Furthermore, the subject of the invention is a method for isolating nucleic acids, in particular DNA, from optional complex starting materials with using the formulations according to the invention which is characterized by the lysis of the starting material, binding of nucleic acids to a carrier, washing of the nucleic acids bound to the carrier and elution of nucleic acids.
Patent DK-1133395-T3 (DK)
Inventor: WAGNER BARBARA
IPC: D06P5/24
Filed: 1999-10-01
Granted: 2006-05-15
Abstract: A color image is printed onto a first substrate, which acts as an intermediate medium, using lithography, intaglio, gravure, relief printing or other printing process which uses plates. The image is subsequently transferred from the intermediate medium to a final substrate, which may be a textile of natural fabric, such as cotton. Bonding and/or crosslinking of the color images are provided by the reaction between compounds selected from each of two chemical groups. The first group comprises compounds with functional groups capable of reacting with active hydrogen, such as isocyanate or epoxy groups. The second group comprises compounds with functional groups containing active hydrogen, or compounds with functional groups containing active hydrogen after a conversion process. The functional groups of one or both reactive chemical groups are protected either by chemical blocking with blocking agents or by physical barrier such as encapsulating agents. The blocking agents are removed by the application of heat during the transfer of the image from the first substrate to the final substrate.
Patent ES-2344828-T3 (ES)
Inventor: BENATTI LUIGI
IPC: A61B/
Filed: 2000-01-13
Granted: 2010-09-08
Abstract: The multipurpose machine for monitoring an control of therapies comprises a head (2) which has a box-like structure, a base (3) to support said head (2) and modifying means (4) for modifying its dimensions.
Patent ES-2199719-T3 (ES)
Title: Racor de valvula de mariposa para motores de combustion.
Inventor: SCHRODER THOMAS
IPC: F02D9/10
Filed: 2000-04-20
Granted: 2004-03-01
Abstract: Racor de válvula de mariposa para un motor de combustión, con una válvula de mariposa (2) que está unida centralmente a un eje de válvula de mariposa (4) montado en un canal de aspiración (3), definiéndose dos mitades de válvula de mariposa (5, 6), en donde la válvula de mariposa (2) está ajustada, en la posición de cierre bajo un ángulo con relación a la línea neutra del canal de aspiración, a la superficie de pared interior (7) del canal de aspiración (3), caracterizado porque la válvula de mariposa (2) se ha ejecutado de forma circular, cilíndrica y plana y la superficie de pared interior (7) del canal de aspiración (3) muestra un contorno elíptico tal que, según se mira en la dirección de cierre, en cada caso la primera arista (9, 10) de una mitad (5, 6) de la válvula de mariposa (2) tiene contacto con la superficie de pared interior (7) del canal de aspiración (3).